Pharmacokinetics of Atazanavir in Special Populations

Conditions:   HIV/AIDS;   Tuberculosis Interventions:   Drug: Atazanavir 300mg/ Ritonavir 100 mg once daily;   Drug: Atazanavir 250 mg / ritonavir 80 mg Sponsors:   University of Liverpool;   Infectious Diseases Institute, Makerere University College of Health Sciences;   Joint Clinical Research Centre- Kampala;   Desmond Tutu HIV Foundation, Cape Town;   University of Cape Town Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials